Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 735 of 1,261
  1. US 9127292

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  2. US 9127068

    Nucleic acids encoding human glucagon receptor antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  3. US 9127057

    Anti-IL-23 heterodimer specific antibodies

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  4. US 9127056

    Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  5. US 9127050

    Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

    Regents of the University of Minnesota · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  6. US 9127027

    Epoxyeicosatrienoic acid analogs and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  7. US 9127021

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  8. US 9126956

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  9. US 9126994

    Crystalline form of a quinolinone-carboxamide compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  10. US 9126978

    1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  11. US 9126941

    Treatment of hyperproliferative disorders with diarylhydantoin compounds

    The Regents of the University of California · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  12. US 9125923

    Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  13. US 9125922

    Phosphate esters of gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  14. US 9125846

    Antibodies that bind amyloid oligomers

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  15. US 9126058

    Mouthwash composition

    FAR EASTERN NEW CENTURY CORPORATION · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  16. US 9125942

    Paramagnetic metal-nanodiamond conjugates

    Northwestern University · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  17. US 9125822

    Particle for medical use and process for producing the same

    SUMITOMO BAKELITE CO., LTD. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  18. US 9125805

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  19. US 9125821

    Nanodrug targeting protein geranylgeranylation

    The Regents of the University of California · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  20. US 9125817

    Dual-cure dental resins and adhesives with increased cure and color-stability and low color

    The Board of Regents of the University of Texas System · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  21. US 9125802

    Dental curable composition

    KURARAY NORITAKE DENTAL INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  22. WO 2015131053

    POLYPEPTIDES DÉRIVÉS DE PHL P, PROCÉDÉS ET UTILISATIONS DE CES DERNIERS POUR MODULER UNE RÉPONSE IMMUNITAIRE

    ALK ABELLÓ AS [DK] · Granted Sep 3, 2015 · Expires Aug 29, 2035

    granted
  23. US 9121016

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  24. US 9120754

    Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof

    Dogwood Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.